Improving Maternal and Neonatal Care-seeking Through a Video-informed Training Session During the Third Trimester of Pregnancy (Taabo T3)
14. september 2026 oppdatert av: Swiss Tropical & Public Health Institute
Improving Maternal and Neonatal Care-Seeking Through a Video-Informed Training Session During the Third Trimester of Pregnancy
This study is a randomized controlled trial evaluating the impact of a video-informed training session on maternal and newborn health care seeking in rural Côte d'Ivoire.
Studieoversikt
Status
Har ikke rekruttert ennå
Intervensjon / Behandling
Detaljert beskrivelse
In Taabo, Côte d'Ivoire, many women do not receive recommended care during the third trimester of pregnancy or the early postpartum period, contributing to adverse maternal and neonatal health outcomes.
In this individual-level open-label randomized controlled trial, we will evaluate the impact of an information and planning intervention on timely care-seeking during the third trimester of pregnancy and the early postpartum period.
The study will enroll 800 women who are currently in the third trimester of pregnancy and randomize them to one of two groups: (1) control, or (2) information video and planning session for the pregnant women and her partner.
A baseline survey will be performed at the time of enrollment, and outcomes will be evaluated using an endline survey 6-8 weeks after the end of pregnancy.
The main outcome of the study is the number of health care contacts that women have between enrollment in the study and 6 weeks postpartum.
Studietype
Intervensjonell
Registrering (Antatt)
800
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Taabo, Côte d’Ivoire
- Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
-
Ta kontakt med:
- Siaka Koné, PhD
- Telefonnummer: +2250749069627
- E-post: Siaka.kone@csrs.ci
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria for Pregnant Women:
- Currently pregnant
- Aged 15 years or older
- Live in the area served by the Taabo Health & Demographic Surveillance System
- Estimated gestational age between 6 completed months of pregnancy and 8 completed months of pregnancy
Inclusion Criteria for Male Partners:
- Aged 15 or older
- Married to or currently the main romantic partner of a woman who is enrolled in the study
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Control group
This group will not receive any intervention.
|
|
|
Eksperimentell: Information Video and Planning Session group
This group will receive the study intervention, including an information video and planning session for the pregnant woman and her partner.
|
The study intervention is a video-informed information and planning session for health care during the third trimester, childbirth, and the first six weeks postpartum.
In this intervention, a member of the study team will show information videos to pregnant women and her partner, summarizing key recommendations for health and health care seeking during the third trimester of pregnancy and the first six weeks following childbirth.
After showing the videos, the study team member will guide the pregnant woman and her partner in a short discussion about planning for care-seeking during the third trimester and early postpartum period.
This discussion will include quizzing on the content of the information videos and discussions of care-seeking plans together with the couple.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of health care contacts as reported by women during endline survey
Tidsramme: From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Number of health care contacts that women have between enrollment in the study and 6 weeks postpartum, including antenatal care visits, childbirth, and postpartum care visits
|
From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of antenatal care visits as reported by women during endline survey
Tidsramme: Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
|
Number of antenatal care visits
|
Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
|
|
Facility-based childbirth as reported by women during endline survey
Tidsramme: Measured 6-8 weeks after the end of pregnancy
|
Proportion of women who gave birth in a health facility
|
Measured 6-8 weeks after the end of pregnancy
|
|
Number of postpartum visits as reported by women during endline survey
Tidsramme: From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Number of postpartum care visits between the end of pregnancy and 6 weeks postpartum
|
From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
|
Fetal movement counting as reported by women during endline surveys
Tidsramme: Measured 6-8 weeks after the end of pregnancy
|
The proportion of pregnant women who report counting fetal movements at least once during the final month of their pregnancy
|
Measured 6-8 weeks after the end of pregnancy
|
|
Perinatal mortality as reported by women during endline surveys
Tidsramme: Measured 6-8 weeks after end of pregnancy
|
The proportion of women who experience a stillbirth or neonatal death in the first seven days of life (perinatal mortality)
|
Measured 6-8 weeks after end of pregnancy
|
|
Neonatal mortality as reported by women during endline surveys
Tidsramme: Measured 6-8 weeks after end of pregnancy
|
The proportion of women whose child dies in the first 28 days of life
|
Measured 6-8 weeks after end of pregnancy
|
|
Average care-seeking knowledge scores among pregnant women and their partners
Tidsramme: Measured 6-8 weeks after the end of pregnancy
|
Average scores (among pregnant women and their partners) on assessments of knowledge of care-seeking recommendations during the third trimester and the early postpartum period, as measured using five questions during endline surveys with pregnant women and their partners. We create a Care-Seeking Knowledge Scale as follows: Participants receive 1 point if they respond with 3 or more when asked how many postpartum visits women should have during the first 6 weeks after childbirth; 1 point if they correctly name at least 3 danger signs for women during pregnancy; 1 point if they correctly name at least 3 danger signs for women during the first six weeks after childbirth; and 1 point if they correctly name at least 3 danger signs for newborns. Scores range from 0 to 4 with higher scores representing greater knowledge. |
Measured 6-8 weeks after the end of pregnancy
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Samarbeidspartnere
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. september 2026
Primær fullføring (Antatt)
1. mai 2027
Studiet fullført (Antatt)
1. mai 2027
Datoer for studieregistrering
Først innsendt
8. september 2026
Først innsendt som oppfylte QC-kriteriene
8. september 2026
Først lagt ut (Faktiske)
14. september 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
17. september 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
14. september 2026
Sist bekreftet
1. september 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2026-19
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
JA
IPD-planbeskrivelse
De-identified data files and analytic code will be posted on public repositories at the time of publication of results.
IPD-delingstidsramme
We plan to share IPD and supporting information at the time of publication.
Tilgangskriterier for IPD-deling
IPD and supporting information will be made available on public repositories.
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- ICF
- ANALYTIC_CODE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .